Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/08/2012US8173588 Iminocarboxylic acid salt-containing solid composition and production method thereof
05/08/2012US8173384 Methods for analyzing or processing a heparin sample
05/08/2012US8173376 Method for identifying compounds for treatment of pain
05/08/2012US8173360 Cell death inhibitor
05/08/2012US8173177 Compositions of botanical extracts for cancer therapy
05/08/2012US8173170 The carrier is bound to a retinoid derivative such as vitamin A or encapsulated with the drug, such as a siRNA against collagen-specific HSP47, in a liposome or micelle and then delivered specifically to astrocytes while minimizing side effects; cirrhosis, liver and pancreatic cancers
05/08/2012US8173168 Dispersible macromolecule compositions and methods for their preparation and use
05/08/2012US8173167 Micelle composition of polymer and passenger drug
05/08/2012US8173164 Both active substances are contained in the same administration unit as two separately formulated subunits
05/08/2012US8173160 Compositions comprising edible oils and vitamins and/or minerals and methods for making the compositions
05/08/2012US8173157 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent
05/08/2012US8173156 Method for avoiding crystallization of anti-inflammatory agent in plaster formulation
05/08/2012US8173149 Method for producing porous β-tricalcium phosphate granules
05/08/2012US8173145 Formulation containing phosphate derivatives of electron transfer agents
05/08/2012US8173142 Pharmaceutical compositions of drugs and neutralized acidic polymers
05/08/2012US8173133 Acyl pseudodipeptides which carry a functionalized auxiliary arm
05/08/2012US8173129 Methods and compositions for treating autoimmune diseases
05/08/2012US8173114 An agent for promoting excretion of an accumulative chlorine compound comprising a pharmaceutically acceptable anion exchange resin, which is a novel agent that is for promoting the excretion of an accumulative chlorine compound and is
05/08/2012US8173113 Bioadhesive composition and patch
05/08/2012US8173107 Delivery of antipsychotics through an inhalation route
05/08/2012DE202006021081U1 Produkte zur Behandlung von Krankheiten Products for the treatment of diseases
05/08/2012CA2757549A1 Pharmacological preparation for topical use containing n-palmitoyl-vanillamide
05/08/2012CA2673751C Protective agent for retinal nerve or optic nerve
05/08/2012CA2659947C New derivatives of diosmetin, process for the preparation thereof and pharmaceutical compounds containing them
05/08/2012CA2632941C New phenanthridine derivatives as bradykinin antagonists
05/08/2012CA2631664C 9-membered heterobicyclic compounds as inhibitors of protein kinases
05/08/2012CA2623339C Virulence genes in the vgc2 cluster of salmonella
05/08/2012CA2593171C Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases
05/08/2012CA2562859C Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug
05/08/2012CA2561628C Histamine h3 receptor agents, preparation and therapeutic uses
05/08/2012CA2561050C Acid addition salts of 5-aminolevulinic acid or its derivatives
05/08/2012CA2550370C Stabilized formulation of ivermectin feed premix with an extended shelf life and method of making the same
05/08/2012CA2544322C Agent for treating chronic pelvic pain syndrome
05/08/2012CA2531905C Specific glucocorticosteroid compound having anti-inflammatory activity
05/08/2012CA2531847C Hfc solution formulations containing an anticholinergic
05/08/2012CA2519195C Adhesive patch containing non-steroidal anti-inflammatory agent
05/08/2012CA2518205C Use of a fibrate and orlistat for the treatment of obesity
05/08/2012CA2517291C Ortho-substituted aryl and heteroaryl tie-2 modulators and methods of use
05/08/2012CA2514356C Novel inhibitors of formation of advanced glycation endproducts (ages)
05/08/2012CA2513660C Hydroxyl compounds and compositions for cholesterol management and related uses
05/08/2012CA2507027C Isoquinoline compounds and medicinal use thereof
05/08/2012CA2495827C 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
05/08/2012CA2492153C Production of polyketide fkbp-ligand analogues
05/08/2012CA2478655C Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/08/2012CA2460042C Inhibition of antigen presentation with poorly catabolized polymers
05/08/2012CA2459224C 1,3-benzothiazinone derivatives and the use thereof
05/08/2012CA2430824C Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
05/08/2012CA2377661C Use of fatty acid derivative for the treatment of external secretion disorders
05/08/2012CA2340593C Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/08/2012CA2333736C Anti-germ attachment skin cleansing composition comprising petrolatum
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/08/2012CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/03/2012WO2012058675A2 Zinc oxide complexes
05/03/2012WO2012058673A2 Enhanced cancer treatment and monitoring using recombinant vectors
05/03/2012WO2012058671A1 Substituted quinazoline and pyrido-pyrimidine derivatives
05/03/2012WO2012058666A2 Novel formulations of water-insoluble chemical compounds and methods of using a formulation of compound fl118 for cancer therapy
05/03/2012WO2012058649A1 Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(-3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
05/03/2012WO2012058642A2 Use of sam68 for modulating signaling through the tnf receptor
05/03/2012WO2012058627A2 Pre-targeted nanoparticle system and method for labeling biological particles
05/03/2012WO2012058601A1 Small molecule inhibitors of bacterial motility and a high throughput screening assay for their identification
05/03/2012WO2012058581A2 Non-hormonal female contraceptive
05/03/2012WO2012058573A1 Use of phosphodiesterase inhibitor to enhance post-surgical erection in men undergoing radical prostatectomy
05/03/2012WO2012058557A2 Personal care compositions comprising a pyrithione and an iron chelator
05/03/2012WO2012058531A2 Modulation of response regulators by imidazole derivatives
05/03/2012WO2012058529A2 Metalloenzyme inhibitor compounds
05/03/2012WO2012058526A1 Inhibition of microbial growth by aconitase inhibition
05/03/2012WO2012058492A2 Viral vaccine and process for preparing the same
05/03/2012WO2012058463A2 Trimegestone (tmg) for treatment of preterm birth
05/03/2012WO2012058424A1 Hypersulfated disaccharides to treat elastase related disorders
05/03/2012WO2012058392A1 Solid dispersions containing an apoptosis-inducing agent
05/03/2012WO2012058325A1 Compounds and methods useful for treatment of diseases mediated by hif-1
05/03/2012WO2012058291A2 Methods and compositions for differentiating embryonic stem cells
05/03/2012WO2012058268A2 Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1
05/03/2012WO2012058254A1 Benzimidazole inhibitors of leukotriene production
05/03/2012WO2012058241A2 Methods and compositions for ameliorating pancreatic cancer
05/03/2012WO2012058224A1 Ophthalmic compositions
05/03/2012WO2012058219A2 Deuterium enriched rasagiline
05/03/2012WO2012058211A2 Quinazoline derivatives, compositions, and uses related thereto
05/03/2012WO2012058210A1 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
05/03/2012WO2012058203A1 Diazeniumdiolate heterocyclic derivatives
05/03/2012WO2012058193A1 Leucine-rich repeat kinase enzyme activity
05/03/2012WO2012058187A1 Cyclic amine substituted oxazolidinone cetp inhibitor
05/03/2012WO2012058176A1 Novel heteroaryl-carboxamide derivatives as pdk1 inhibitors
05/03/2012WO2012058174A1 Novel thiazole-carboxamide derivatives as pdk1 inhibitors
05/03/2012WO2012058173A1 Hiv integrase inhibitors
05/03/2012WO2012058134A1 Inhibitors of the renal outer medullary potassium channel
05/03/2012WO2012058133A1 Isoindolinone pde10 inhibitors
05/03/2012WO2012058130A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
05/03/2012WO2012058129A1 Process for the preparation of an orexin receptor antagonist
05/03/2012WO2012058128A2 Caprolactam mglur5 receptor modulators
05/03/2012WO2012058125A1 Inhibitors of hepatitis c virus
05/03/2012WO2012058116A1 Inhibitors of the renal outer medullary potassium channel
05/03/2012WO2012058115A2 Anti-cancer serine hydrolase inhibitory carbamates
05/03/2012WO2012058091A2 Aripiprazole compositions and methods for its transdermal delivery
05/03/2012WO2012058073A2 Methods and compositions to protect aquatic invertebrates from disease
05/03/2012WO2012058065A1 Boronates as arginase inhibitors
05/03/2012WO2012057894A1 Econazole composition and methods of treatment therewith
05/03/2012WO2012057713A1 Antimicrobial peptides
05/03/2012WO2012057599A1 Anti-mycobacterial agents
05/03/2012WO2012057492A2 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein a-i and a mutant thereof
1 ... 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 ... 7860